$3.79T
Total marketcap
$140.35B
Total volume
BTC 57.94%     ETH 12.28%
Dominance

Stereotaxis STXS Stock

2.91 USD {{ price }} -0.342465% {{change_pct}}%
Market Cap
265.92M USD
LOW - HIGH [24H]
2.89 - 2.98 USD
VOLUME [24H]
287.47K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.29 USD

Stereotaxis Price Chart

Stereotaxis STXS Financial and Trading Overview

Stereotaxis stock price 2.91 USD
Previous Close 2.25 USD
Open 2.28 USD
Bid 2.19 USD x 900
Ask 2.2 USD x 500
Day's Range 2.19 - 2.29 USD
52 Week Range 1.54 - 2.72 USD
Volume 114.03K USD
Avg. Volume 394.02K USD
Market Cap 198.55M USD
Beta (5Y Monthly) 1.508
PE Ratio (TTM) N/A
EPS (TTM) -0.29 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 4.5 USD

STXS Valuation Measures

Enterprise Value 194.06M USD
Trailing P/E N/A
Forward P/E -12.222222
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.2174397
Price/Book (mrq) 66.66667
Enterprise Value/Revenue 7.054
Enterprise Value/EBITDA -8.635

Trading Information

Stereotaxis Stock Price History

Beta (5Y Monthly) 1.508
52-Week Change 21.62%
S&P500 52-Week Change 19.28%
52 Week High 2.72 USD
52 Week Low 1.54 USD
50-Day Moving Average 2.24 USD
200-Day Moving Average 2.12 USD

STXS Share Statistics

Avg. Volume (3 month) 394.02K USD
Avg. Daily Volume (10-Days) 1.01M USD
Shares Outstanding 90.25M
Float 60.59M
Short Ratio 13.46
% Held by Insiders 29.61%
% Held by Institutions 44.32%
Shares Short 3.94M
Short % of Float 6.87%
Short % of Shares Outstanding 4.58%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1096:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 31, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin -92.18%
Operating Margin (ttm) -79.34%
Gross Margin 53.40%
EBITDA Margin -81.69%

Management Effectiveness

Return on Assets (ttm) -34.74%
Return on Equity (ttm) -179.82%

Income Statement

Revenue (ttm) 27.51M USD
Revenue Per Share (ttm) 0.32 USD
Quarterly Revenue Growth (yoy) 8.59%
Gross Profit (ttm) 14.69M USD
EBITDA -22474000 USD
Net Income Avi to Common (ttm) -26652000 USD
Diluted EPS (ttm) -0.31
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 10.6M USD
Total Cash Per Share (mrq) 0.12 USD
Total Debt (mrq) 5.87M USD
Total Debt/Equity (mrq) 71.77 USD
Current Ratio (mrq) 1.07
Book Value Per Share (mrq) 0.033

Cash Flow Statement

Operating Cash Flow (ttm) -7930000 USD
Levered Free Cash Flow (ttm) 6.07M USD

Profile of Stereotaxis

Country United States
State MO
City Saint Louis
Address 710 North Tucker Boulevard
ZIP 63101
Phone 314 678 6100
Website https://www.stereotaxis.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 139

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Q&A For Stereotaxis Stock

What is a current STXS stock price?

Stereotaxis STXS stock price today per share is 2.91 USD.

How to purchase Stereotaxis stock?

You can buy STXS shares on the NYSE American exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Stereotaxis?

The stock symbol or ticker of Stereotaxis is STXS.

Which industry does the Stereotaxis company belong to?

The Stereotaxis industry is Medical Instruments & Supplies.

How many shares does Stereotaxis have in circulation?

The max supply of Stereotaxis shares is 91.38M.

What is Stereotaxis Price to Earnings Ratio (PE Ratio)?

Stereotaxis PE Ratio is now.

What was Stereotaxis earnings per share over the trailing 12 months (TTM)?

Stereotaxis EPS is -0.29 USD over the trailing 12 months.

Which sector does the Stereotaxis company belong to?

The Stereotaxis sector is Healthcare.

Stereotaxis STXS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
US Tech Composite Total Return XCMP 29137.78 USD
+0.62
29019.72 USD 29409.52 USD
✨New! Portfolio🚀